Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Tenaya Therapeutics Inc’s stock clocked out at $2.57, down -6.88% from its previous closing price of $2.76. In other words, the price has decreased by -$6.88 from its previous closing price. On the day, 6.09 million shares were traded. TNYA stock price reached its highest trading level at $3.03 during the session, while it also had its lowest trading level at $2.45.
Ratios:
To gain a deeper understanding of TNYA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.27 and its Current Ratio is at 5.27. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.10.
On November 30, 2023, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.
On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.H.C. Wainwright initiated its Buy rating on June 15, 2022, with a $25 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 16 ’24 when Saito Chihiro sold 2,363 shares for $2.89 per share. The transaction valued at 6,840 led to the insider holds 63,241 shares of the business.
Tingley Whittemore sold 7,428 shares of TNYA for $21,500 on Aug 16 ’24. The Chief Medical Officer now owns 107,106 shares after completing the transaction at $2.89 per share. On Aug 16 ’24, another insider, Ali Faraz, who serves as the Chief Executive Officer of the company, sold 9,748 shares for $2.89 each. As a result, the insider received 28,216 and left with 188,331 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNYA now has a Market Capitalization of 203596672 and an Enterprise Value of 138665728.
Stock Price History:
Over the past 52 weeks, TNYA has reached a high of $7.01, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is 25.80%, while the 200-Day Moving Average is calculated to be -29.51%.
Shares Statistics:
It appears that TNYA traded 1.44M shares on average per day over the past three months and 6628150 shares per day over the past ten days. A total of 68.33M shares are outstanding, with a floating share count of 65.58M. Insiders hold about 17.22% of the company’s shares, while institutions hold 56.90% stake in the company. Shares short for TNYA as of 1728950400 were 4876224 with a Short Ratio of 3.39, compared to 1726185600 on 5222661. Therefore, it implies a Short% of Shares Outstanding of 4876224 and a Short% of Float of 8.870000000000001.
Earnings Estimates
Investors are keenly observing as 9.0 analysts analyze and rate the current performance of Tenaya Therapeutics Inc (TNYA) in the stock market.The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.3 and low estimates of -$0.36.
Analysts are recommending an EPS of between -$1.31 and -$1.74 for the fiscal current year, implying an average EPS of -$1.39. EPS for the following year is -$1.41, with 8.0 analysts recommending between -$1.1 and -$1.94.
